Fowzul Islam Fahad

Mr. Fowzul Islam Fahad

International Islamic University Chittagong
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2021 in Life
Verified
Journal Article
Open access
PDF file
Fowzul Islam FahadFowzul Islam Fahad
Fowzul Islam Fahad
NBNiloy Barua
Niloy Barua
SIShafiqul Islam
Shafiqul Islam
SSSyed Al Jawad Sayem
Syed Al Jawad Sayem
KBKoushik Barua
Koushik Barua
Raffaele CapassoRaffaele Capasso
Raffaele Capasso
Lepidagathis hyalina Nees is used locally in Ayurvedic medicine to treat coughs and cardiovascular diseases. This study explored its pharmacological potential through in vivo and in vitro approaches for the metabolites extracted (methanolic) from the stems of L. hyalina. A qualitative phytochemical analysis revealed the presence of numerous secondary metabolites. The methanol extract of L. hyalina stems (MELHS) showed a strong antioxidative activity in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) and reducing power assays, and in the quantitative (phenolic and flavonoid) assay. Clot lysis and brine shrimp lethality bioassays were applied to investigate the thrombolytic and cytotoxic activities, respectively. MELHS exhibited an expressive percentage of clot lysis (33.98%) with a moderately toxic (115.11 μg/mL) effect. The in vivo anxiolytic activity was studied by an elevated plus maze test, whereas the antidepressant activity was examined by a tail suspension test and forced swimming test. During the anxiolytic evaluation, MELHS exhibited a significant dose-dependent reduction of anxiety, in which the 400 mg/kg dose of the extract showed 78.77 ± 4.42% time spent in the open arm in the elevated plus maze test. In addition, MELHS demonstrated dose-dependent and significant activities in the tail suspension test and forced swimming test, whereas the 400 mg/kg dose of the extract showed 87.67 ± 6.40% and 83.33 ± 6.39% inhibition of immobile time, respectively. Therefore, the current study suggests that L. hyalina could be a potential source of anti-oxidative, cytotoxic, thrombolytic, anxiolytic, and antidepressant agents. Further study is needed to determine the mechanism behind the bioactivities.

9 June 2025 in Onco
Verified
Journal Article
Open access
PDF file
Sandhya A. ShuklaSandhya A. Shukla
Sandhya A. Shukla
Arvind Kumar ShuklaArvind Kumar Shukla
Arvind Kumar Shukla
Adarsha Mahendra UpadhyayAdarsha Mahendra Upadhyay
Adarsha Mahendra Upadhyay
NRNavin Ray
Navin Ray
Fowzul Islam FahadFowzul Islam Fahad
Fowzul Islam Fahad
RMRAJ MONGRE
RAJ MONGRE
Breast cancer is one of the most common and difficult-to-treat cancers affecting women globally. Long-term treatment success is still limited by problems like drug resistance, toxicity, and recurrence, even with advancements in conventional therapies. The application of substances derived from plants for medical purposes, or phytotherapy, has become a viable adjunctive approach to the treatment of breast cancer. An integrative approach to phytotherapy is examined in this review, focusing on how it can alter important molecular pathways implicated in the development, progression, and metastasis of breast cancer. By focusing on important signaling cascades like TGF-β, Wnt, Hedgehog, Notch, IL-6, Integrins, VEGF, HER2, EGFR, PI3K/Akt, and MAPK, and estrogen receptor pathways, a variety of phytochemicals, such as flavonoids, alkaloids, terpenoids, and polyphenols, demonstrate strong anticancer effects. This review also discusses how they affect immune modulation, angiogenesis, cell cycle regulation, and apoptosis. Moreover, it also emphasizes the challenges with these natural compounds’ bioavailability, standardization, and clinical translation while highlighting preclinical and clinical research that supports their therapeutic potential. This review attempts to give a thorough grasp of how plant-based compounds can support efficient and focused breast cancer treatments by fusing molecular insights with phytotherapeutic approaches.

9 May 2025 in Onco
Verified
Journal Article
Open access
PDF file
Sandhya A. ShuklaSandhya A. Shukla
Sandhya A. Shukla
Arvind Kumar ShuklaArvind Kumar Shukla
Arvind Kumar Shukla
NRNavin Ray
Navin Ray
Adarsha Mahendra UpadhyayAdarsha Mahendra Upadhyay
Adarsha Mahendra Upadhyay
Fowzul Islam FahadFowzul Islam Fahad
Fowzul Islam Fahad
RMRAJ MONGRE
RAJ MONGRE
Globally, women’s cancer-related morbidity and death are still caused mainly by gynecologic cancer. Antioxidant and anti-inflammatory drugs have shown promise in treating gynecologic cancer because of the complex interactions among oxidative stress, inflammation, and the development of tumors. This review focuses on how these drugs, which include polyphenols, terpenoids, and thiols-related phytochemical-derived compounds target different pathways associated with developing and progressing gynecologic cancer. We investigate what factors affect the tumor microenvironment, specifically how they affect immunological response and vasculogenesis. Through the review of recent studies, we have gained an extensive understanding of the molecular pathways that anti-inflammatory and antioxidant drugs use to achieve their therapeutic benefits. Gynecologic cancer is still a potent cause of cancer-related deaths and fatalities for women globally. Antioxidant and anti-inflammatory drugs have shown promise in treating gynecologic cancer because of the complex interactions among oxidative stress, inflammation, and the development of tumors. This review focuses on how these drugs target different pathways associated with developing and progressing gynecologic cancer. We investigate what factors affect the tumor microenvironment, specifically how they affect immunological response and vasculogenesis. Through the review of recent studies, we have gained an extensive understanding of the molecular pathways that anti-inflammatory and antioxidant drugs use to achieve their therapeutic benefits.

19 November 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
JAJahid Hasan Azad
Jahid Hasan Azad
Fowzul Islam FahadFowzul Islam Fahad
Fowzul Islam Fahad
KBKoushik Barua
Koushik Barua
SAS. M. Asadul Karim Azad
S. M. Asadul Karim Azad
Safaet AlamSafaet Alam
Safaet Alam
Mohammad Nazmul IslamMohammad Nazmul Islam
Mohammad Nazmul Islam
Arenga porphyrocarpa palm tree roots and buds are used to treat urinary incontinence, fever, appetite loss, and as a diuretic. Our study aimed to evaluate the neuropharmacological, antioxidant, cytotoxic, and thrombolytic potentials of A. porphyrocarpa leaf and stem extracts through in vivo, in vitro and in silico studies. Different fractions of A. porphyrocarpa leaves and stems were investigated for anxiolytic and anti‐depressant efficacy through EPM and HBT and TST and FST tests. The anti‐oxidant assessment was assessed by using DPPH and reducing power assays, while thrombolytic efficacy was analyzed by clot lysis technique. Computational methods like in silico molecular docking, pass prediction and ADME/T were applied to evaluate several pharmacological properties of 15 selected compounds from GC–MS analysis of plant extract. Both doses of the plant extract fractions (200 and 400 mg/kg) showed dose‐dependent anxiolytic and antidepressant‐like effects in mice, with the 400 mg/kg dose found to have highly significant ( p < 0.001) effects. Among the fractions, the chloroform fraction of A. porphyrocarpa leaves (CFAPL) exhibited the strongest antioxidant activity, as indicated by its DPPH scavenging potential (IC₅₀ = 128.94 μg/mL), and also demonstrated the most effective clot lysis. In silico analysis further revealed that several bioactive compounds had strong binding affinities to target proteins, including isobutyric acid 2,2,2‐trichloroethyl ester (anxiolytic activity), 2‐cyclobutene‐1‐carboxamide (antidepressant activity), 2‐pyridinecarboxylic acid (antioxidant activity), propionic acid 3‐(isobutylthio)‐ (cytotoxic), and 2‐propanone 1‐hydroxy‐ (thrombolytic activity). Ongoing investigations indicate that A. porphyrocarpa is a promising candidate for the treatment of neuropsychiatric and cardiovascular disorders; however, further cytotoxicity studies and confirmation of the specific bioactive compounds responsible for its biological activities are needed.